Patients starting GLP-1 therapy Patients adjusting doses Patients wanting to reduce side effects or progress Patients who love data or structure The Meds Supported medications Shotsy supports commonly prescribed GLP-1 treatments, including semaglutide and tirzepatide, in both injectable and oral forms, as well as brand-name and compounded options
(These tasks can be complicated by GLP-1 medications, which commonly cause nausea, vomiting and reduced appetite.) Restarting GLP-1 medications may be an option, Buie said, for the following reasons: Weight loss eventually plateaus or stalls after bariatric surgery Additional bariatric surgery isn't possible (such as converting a sleeve gastrectomy to a duodenal switch) Weight regain has occurred years after having bariatric surgery
Insurance coverage expansion through commercial plans and Medicare Advantage products improves treatment accessibility across demographic segments
Particularly for heart failure, several clinical trials and meta-analyses have already confirmed that SGLT2is reduce HHF by approximately 30% in both HFrEF and HFpEF, with or without diabetes [46]
Comparison decision path Use this comparison to narrow the provider review question Direct answer Mochi Health vs Ro for GLP-1: Two Rising Telehealth Platforms should help you decide which option deserves a clinical review, not force a one-size answer
What is Ozempic
